1293487-52-1

Upstream product

• 141699-59-4 1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate 
• 180695-80-1 tert-butyl 4-azidopiperidine-1-carboxylate 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 1221591-51-0 C₈H₁₄N₆O 
• 65-85-0 benzoic acid 
• 1174931-49-7 tert-butyl 4-(4-(ethoxy carbonyl)-1H-1,2,3-triazol-1-yl)piperidine-1-carboxylate 
• 1174931-52-2 tert-butyl 4-(4-(N'-hydroxycarbamimidoyl)-1H-1,2,3-triazol-1-yl)piperidine-1-carboxylate 
• 1174931-51-1 tert-butyl 4-(4-cyano-1H-1,2,3-triazol-1-yl)piperidine-1-carboxylate 

Relevant academic research and scientific papers

Synthesis of some novel 3-(1-(1-substitutedpiperidin-4-yl)-1H-1,2,3- triazol-4-yl)-5-substituted phenyl-1,2,4-oxadiazoles as antifungal agents

A novel series of 3-(1-(1-substituted piperidin-4-yl)-1H-1,2,3-triazol-4- yl)-5-substituted phenyl-1,2,4-oxadiazoles bearing 1,2,3-triazole and piperidine ring has been synthesized in one step from amidoxime using Carbonyl diimidazole (CDI) and K2CO3. All the synthesized compounds (4a-4r) are novel and evaluated for their in vitro antifungal activities. SAR for the series has been developed by comparing their MIC values with miconazole and fluconazole. Some of the compounds from the series like 4j was equipotent with miconazole against Cryptococcus neoformans whereas activities of compound 4m against Aspergillus niger and Aspergillus flavus were comparable to miconazole. Also compound 4r shows activity comparable to miconazole against Candida albicans, A. niger and A. flavus.